“…Several studies have reported diagnostic cutoffs for ARFI‐measured liver stiffness for predicting advanced liver fibrosis and, more recently, spleen stiffness for esophageal varices 4 , 21 , 22 . However, standards for use of ARFI have not been established, and there are limited data available concerning the reproducibility of ARFI measurements in the liver 11 , 12 , 22 , 23 and none concerning the reproducibility of ARFI measurements in the spleen among patients under evaluation for chronic liver disease. Moreover, the few studies that did report intraobserver and interobserver variability of ARFI were conducted in countries with much lower prevalence rates of obesity than the United States, where the prevalence rate of obesity is estimated at 35% 23 .…”